OGEN Oragenics Inc

Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.

$0.32  +0.03 (8.48%)
As of 06/24/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  05/20/2004
Outstanding shares:  116,394,806
Average volume:  406,270
Market cap:   $34,336,468
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -16.25
PB ratio:   2.08
PS ratio:   0.00
Return on equity:   -69.31%
Net income %:   -16,365,995.61%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy